In contrast, PAAD patients with high mRNA expression of E2F4/7/8 were significantly related with longer OS, while E2F6 transcription levels were not associated with OS in PAAD patients (Figure 6). This evidence concerns the gene E2F6 and pancreatic adenocarcinoma.